Hazards ratios (HR) and 95% confidence intervals (CI) were collected to estimate the correlation between overexpression and amplification of FGFR1 and survival outcomes of HNSCC patients. This evidence concerns the gene FGFR1 and head and neck squamous cell carcinoma.